The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Deuterated Drugs Market Research Report 2025
Synopsis
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
The global Deuterated Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Deuterated Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deuterated Drugs.
Report Scope
The Deuterated Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deuterated Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deuterated Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
Segment by Type
Austedo
Zepsun
Others
Segment by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
The global Deuterated Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Deuterated Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deuterated Drugs.
Report Scope
The Deuterated Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deuterated Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deuterated Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
Segment by Type
Austedo
Zepsun
Others
Segment by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deuterated Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Austedo
1.2.3 Zepsun
1.2.4 Others
1.3 Market by Application
1.3.1 Global Deuterated Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Huntington'S Disease (HD)
1.3.3 Tardive Dyskinesia (TD)
1.3.4 Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Deuterated Drugs Market Perspective (2019-2030)
2.2 Deuterated Drugs Growth Trends by Region
2.2.1 Global Deuterated Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Deuterated Drugs Historic Market Size by Region (2019-2024)
2.2.3 Deuterated Drugs Forecasted Market Size by Region (2025-2030)
2.3 Deuterated Drugs Market Dynamics
2.3.1 Deuterated Drugs Industry Trends
2.3.2 Deuterated Drugs Market Drivers
2.3.3 Deuterated Drugs Market Challenges
2.3.4 Deuterated Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Deuterated Drugs Players by Revenue
3.1.1 Global Top Deuterated Drugs Players by Revenue (2019-2024)
3.1.2 Global Deuterated Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Deuterated Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Deuterated Drugs Revenue
3.4 Global Deuterated Drugs Market Concentration Ratio
3.4.1 Global Deuterated Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deuterated Drugs Revenue in 2023
3.5 Deuterated Drugs Key Players Head office and Area Served
3.6 Key Players Deuterated Drugs Product Solution and Service
3.7 Date of Enter into Deuterated Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Deuterated Drugs Breakdown Data by Type
4.1 Global Deuterated Drugs Historic Market Size by Type (2019-2024)
4.2 Global Deuterated Drugs Forecasted Market Size by Type (2025-2030)
5 Deuterated Drugs Breakdown Data by Application
5.1 Global Deuterated Drugs Historic Market Size by Application (2019-2024)
5.2 Global Deuterated Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Deuterated Drugs Market Size (2019-2030)
6.2 North America Deuterated Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Deuterated Drugs Market Size by Country (2019-2024)
6.4 North America Deuterated Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Deuterated Drugs Market Size (2019-2030)
7.2 Europe Deuterated Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Deuterated Drugs Market Size by Country (2019-2024)
7.4 Europe Deuterated Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Deuterated Drugs Market Size (2019-2030)
8.2 Asia-Pacific Deuterated Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Deuterated Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Deuterated Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Deuterated Drugs Market Size (2019-2030)
9.2 Latin America Deuterated Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Deuterated Drugs Market Size by Country (2019-2024)
9.4 Latin America Deuterated Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Deuterated Drugs Market Size (2019-2030)
10.2 Middle East & Africa Deuterated Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Deuterated Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Deuterated Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Deuterated Drugs Introduction
11.1.4 Teva Revenue in Deuterated Drugs Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Introduction
11.2.4 Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2019-2024)
11.2.5 Suzhou Zelgen Biopharmaceuticals Recent Development
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Detail
11.3.2 Concert Pharmaceuticals Business Overview
11.3.3 Concert Pharmaceuticals Deuterated Drugs Introduction
11.3.4 Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2019-2024)
11.3.5 Concert Pharmaceuticals Recent Development
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Detail
11.4.2 Vertex Pharmaceuticals Business Overview
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Introduction
11.4.4 Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2019-2024)
11.4.5 Vertex Pharmaceuticals Recent Development
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Detail
11.5.2 Hinova Pharma Business Overview
11.5.3 Hinova Pharma Deuterated Drugs Introduction
11.5.4 Hinova Pharma Revenue in Deuterated Drugs Business (2019-2024)
11.5.5 Hinova Pharma Recent Development
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Detail
11.6.2 Otsuka Pharmaceutical (Avanir) Business Overview
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Introduction
11.6.4 Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2019-2024)
11.6.5 Otsuka Pharmaceutical (Avanir) Recent Development
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Detail
11.7.2 Poxel SA (DeuteRx) Business Overview
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Introduction
11.7.4 Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2019-2024)
11.7.5 Poxel SA (DeuteRx) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Deuterated Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Austedo
Table 3. Key Players of Zepsun
Table 4. Key Players of Others
Table 5. Global Deuterated Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Deuterated Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Deuterated Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Deuterated Drugs Market Share by Region (2019-2024)
Table 9. Global Deuterated Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Deuterated Drugs Market Share by Region (2025-2030)
Table 11. Deuterated Drugs Market Trends
Table 12. Deuterated Drugs Market Drivers
Table 13. Deuterated Drugs Market Challenges
Table 14. Deuterated Drugs Market Restraints
Table 15. Global Deuterated Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Deuterated Drugs Market Share by Players (2019-2024)
Table 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)
Table 18. Ranking of Global Top Deuterated Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Deuterated Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Deuterated Drugs Product Solution and Service
Table 22. Date of Enter into Deuterated Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Deuterated Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Deuterated Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Deuterated Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Deuterated Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Deuterated Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Deuterated Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Deuterated Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Deuterated Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Deuterated Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Deuterated Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Deuterated Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Deuterated Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Deuterated Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Deuterated Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Deuterated Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Deuterated Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Deuterated Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Deuterated Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Deuterated Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Deuterated Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Deuterated Drugs Product
Table 50. Teva Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 53. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 54. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product
Table 55. Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 56. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 57. Concert Pharmaceuticals Company Detail
Table 58. Concert Pharmaceuticals Business Overview
Table 59. Concert Pharmaceuticals Deuterated Drugs Product
Table 60. Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 61. Concert Pharmaceuticals Recent Development
Table 62. Vertex Pharmaceuticals Company Detail
Table 63. Vertex Pharmaceuticals Business Overview
Table 64. Vertex Pharmaceuticals Deuterated Drugs Product
Table 65. Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 66. Vertex Pharmaceuticals Recent Development
Table 67. Hinova Pharma Company Detail
Table 68. Hinova Pharma Business Overview
Table 69. Hinova Pharma Deuterated Drugs Product
Table 70. Hinova Pharma Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 71. Hinova Pharma Recent Development
Table 72. Otsuka Pharmaceutical (Avanir) Company Detail
Table 73. Otsuka Pharmaceutical (Avanir) Business Overview
Table 74. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product
Table 75. Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 76. Otsuka Pharmaceutical (Avanir) Recent Development
Table 77. Poxel SA (DeuteRx) Company Detail
Table 78. Poxel SA (DeuteRx) Business Overview
Table 79. Poxel SA (DeuteRx) Deuterated Drugs Product
Table 80. Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2019-2024) & (US$ Million)
Table 81. Poxel SA (DeuteRx) Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deuterated Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Deuterated Drugs Market Share by Type: 2023 VS 2030
Figure 3. Austedo Features
Figure 4. Zepsun Features
Figure 5. Others Features
Figure 6. Global Deuterated Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Deuterated Drugs Market Share by Application: 2023 VS 2030
Figure 8. Huntington'S Disease (HD) Case Studies
Figure 9. Tardive Dyskinesia (TD) Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Deuterated Drugs Report Years Considered
Figure 13. Global Deuterated Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Deuterated Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Deuterated Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Deuterated Drugs Market Share by Players in 2023
Figure 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Deuterated Drugs Revenue in 2023
Figure 19. North America Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Deuterated Drugs Market Share by Country (2019-2030)
Figure 21. United States Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Deuterated Drugs Market Share by Country (2019-2030)
Figure 25. Germany Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Deuterated Drugs Market Share by Region (2019-2030)
Figure 33. China Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Deuterated Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Deuterated Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Deuterated Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Teva Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 48. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 49. Concert Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 50. Vertex Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 51. Hinova Pharma Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 52. Otsuka Pharmaceutical (Avanir) Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 53. Poxel SA (DeuteRx) Revenue Growth Rate in Deuterated Drugs Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
